Displaying drugs 11676 - 11700 of 12884 in total
GRObeta
Investigational
Osemitamab
Investigational
Tagitanlimab
Investigational
TSHA-104
Investigational
XMT-2056
XMT-2056 is a HER2-targeted antibody-drug conjugate (ADC) consisting of a HER2-targeted antibody conjugated with a stimulator of interferon genes (STING) agonist payload.
Investigational
DF-1001
Investigational
IBIO-100
IBIO-100 is a high molecular weight multimer of E3-Fc, an endostatin C-terminus and IgG1-Fc fusion protein.
Investigational
TLR-AD1
Investigational
BD-111
BD-111 is an HSV-1-erasing lentivirus-like particle delivering gRNA-expressing cassette and SpCas9 mRNA.
Investigational
Human autologous bone marrow derived osteoblastic cells
Investigational
Human glial progenitor cells
Investigational
HM15912
HM15912 is a human glucagon-like peptide-2 analogue linked to a human immunoglobulin Fc fragment.
Investigational
LX2006
Investigational
SP-101
Investigational
OT-004
Investigational
TSHA-101
Investigational
CT-001
Investigational
AO-176
Investigational
Ulenistamab
Investigational
CM-101
Investigational
4D-110
Investigational
JAG101
Investigational
4D-310
4D-310 is a adeno-Associated Virus Serotype 2 capsid variant (4D-C102) carrying a transgene encoding a codon-optimized human alpha-galactosidase A gene
Investigational
BMN-331
Investigational
OptPA
Optimized tPA (OptPA; W253R/R275S-tPA) is an engineered variant of tPA designed to exhibit reduced neurotoxicity.
Investigational
Displaying drugs 11676 - 11700 of 12884 in total